No Evidence for Association of the MDM2 −309 T/G Promotor Polymorphism with Prostate Cancer Outcomes

OBJECTIVES: MDM2 SNP309 polymorphism (T>G) has been correlated with an increased risk of cancer in multiple tumor types. MDM2 overexpression in has shown to be weakly associated with distant tumor metastases, and downregulation of MDM2 via antisense oligonucleotides in vitro has resulted in the r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jaboin, Jerry J., Hwang, Misun, Perez, Carmen A., Cooper, Calvin, Chen, Heidi, Ye, Chuanzhong, Cai, Qiuyin, Wills, Marcia L., Lu, Bo
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782416/
https://ncbi.nlm.nih.gov/pubmed/19523862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2009.03.031
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares